Wednesday, July 8, 2026

pharma · Colonic disease

Norgine

Norgine patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Amsterdam, NL HQ
1906 Founded
1,160 Employees
TGA registrant Type
Company details
Status
Public
HQ
Amsterdam, NL
Founded
1906
Employees
1,160
Programs
1
Drugs
3
Patents
0
Intelligence · Patents

Norgine patents

0 pharmaceutical patents indexed for Norgine. 0 expire within 24 months.

Norgine has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

No patents matched

Try a different expiry filter or check back as we index more USPTO records.

Frequently asked questions

How many patents does Norgine have?

0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Norgine patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.